These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26466220)

  • 1. A preliminary analysis of the reduction of chemotherapy waste in the treatment of cancer with centralization of drug preparation.
    Hyeda A; Costa ES
    Rev Assoc Med Bras (1992); 2015 Aug; 61(4):368-74. PubMed ID: 26466220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Centralization impact and cost-saving study in a Moroccan hospital's centralized unit of chemotherapy preparation.
    Adade CA; Benabbes M; Belahcen MJ; Rahali Y
    J Oncol Pharm Pract; 2020 Oct; 26(7):1630-1636. PubMed ID: 32046581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Not Available].
    Hyeda A; da Costa ESM
    Value Health Reg Issues; 2015 Dec; 8():107-111. PubMed ID: 29698161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ideal vial size for bortezomib: real-world data on waste and cost reduction in treatment of multiple myeloma in Brazil.
    Clark L; Castro AP; Fortes AF; Santos F; Clark O; Engel T; Pegoretti B; Teich V; Vianna D; Puty F
    Value Health; 2011; 14(5 Suppl 1):S82-4. PubMed ID: 21839906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost savings realized by use of the PhaSeal(®) closed-system transfer device for preparation of antineoplastic agents.
    Edwards MS; Solimando DA; Grollman FR; Pang JL; Chasick AH; Hightman CM; Johnson AD; Mickens MG; Preston LM
    J Oncol Pharm Pract; 2013 Dec; 19(4):338-47. PubMed ID: 23975556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the potential impact of dose rounding parenteral chemotherapy agents on cost savings and drug waste minimization.
    Chillari KA; Southward J; Harrigan N
    J Oncol Pharm Pract; 2018 Oct; 24(7):507-510. PubMed ID: 28732452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of a standardised pharmacist check of medical orders prior to preparation of anticancer drugs to reduce drug wastage.
    Yamada H; Kobayashi R; Shimizu S; Yamada Y; Ishida M; Shimoda H; Kato-Hayashi H; Fujii H; Iihara H; Tanaka H; Suzuki A
    Int J Clin Pract; 2020 Apr; 74(4):e13464. PubMed ID: 31830345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Availability and affordability of anticancer medicines at the Ocean Road Cancer Institute in Dar es Salaam, Tanzania.
    Yohana E; Kamuhabwa A; Mujinja P
    East Afr J Public Health; 2011 Mar; 8(1):52-7. PubMed ID: 22066285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cost of functioning of a centralised pharmaceutical unit: evaluation of mean costs of chemotherapy preparations according to the level of production of the unit].
    Galy G; Bauler S; Buchi M; Pirot F; Pivot C
    Bull Cancer; 2011 Oct; 98(10):1153-63. PubMed ID: 22001702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the implementation of vasoactive drug protocols on costs in the treatment of critically ill patients.
    Cuesta-López I; Sánchez-Cuervo M; Candela-Toha Á; Benedí-González J; Bermejo-Vicedo T
    Farm Hosp; 2018 Mar; 42(2):62-67. PubMed ID: 29501057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential cost savings associated with dose rounding antineoplastic monoclonal agents.
    Francis SM; Heyliger A; Miyares MA; Viera M
    J Oncol Pharm Pract; 2015 Aug; 21(4):280-4. PubMed ID: 24821690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Centralized intravenous additive services (CIVAS): the state of the art in 2010.
    Hecq JD
    Ann Pharm Fr; 2011 Jan; 69(1):30-7. PubMed ID: 21296215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Economical assessment of intravenous mixture centralization].
    Martínez-Tutor MJ
    Farm Hosp; 2006; 30(6):351-8. PubMed ID: 17298192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Financial impact from in-office dispensing of oral chemotherapy.
    Howard A; Kerr J; McLain M; Modlin J
    J Oncol Pharm Pract; 2019 Oct; 25(7):1570-1575. PubMed ID: 30249154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Centralized preparations of cytostatic agents: a method for quality control].
    Wernli M; Bögli F; Mühlebach S; Conen D
    Schweiz Med Wochenschr; 1994 Nov; 124(44):1962-5. PubMed ID: 7973528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. It is not only the empty vials that go into the garbage can during chemotherapy drugs preparation: a cost analysis of unused chemotherapy drugs in cancer treatment.
    Ata A; Abali H; Yengel E; Arican A
    J BUON; 2012; 17(4):781-4. PubMed ID: 23335541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Centralized compounding of cytostatics results in better service and lower cost].
    Eklund LH; Juneskans OT; Mellstedt H; Montelius C
    Lakartidningen; 1991 Mar; 88(12):1108-9. PubMed ID: 1901929
    [No Abstract]   [Full Text] [Related]  

  • 18. Reusing cytostatics in a centralised pharmacy preparation unit.
    Ramos Linares S; Merino Alonso J; Román González N; Tévar Alfonso E; Díaz Ruíz P; Gorchs Molist M
    Farm Hosp; 2011; 35(2):70-4. PubMed ID: 20869287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Costs of a cytostatic drug preparation unit in a hospital in Mexico].
    Martínez Rodríguez OA; Rivas Bocanegra RE; Ascencio-Pérez IS; Zapata Sánchez LA
    Farm Hosp; 2007; 31(6):375-8. PubMed ID: 18348668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential cost savings by dose down-rounding of monoclonal antibodies in a community cancer center.
    Copur MS; Gnewuch C; Schriner M; Tharnish M; Gonen M; McDonald M; Kezeor J; Ramaekers RC; Gauchan D; Clark D; Greenwalt L; Mickey M; Norvell M
    J Oncol Pharm Pract; 2018 Mar; 24(2):116-120. PubMed ID: 29284380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.